{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T17:09:01Z","timestamp":1784135341703,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.thromres.2026.109752","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:44:14Z","timestamp":1781624654000},"page":"109752","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Bleeding risk in patients receiving concurrent treatment with direct oral anticoagulants and corticosteroids: A systematic review"],"prefix":"10.1016","volume":"263","author":[{"given":"Rosa","family":"Talerico","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Cavallaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Iorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Alessandra","family":"Capparella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Porfidia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Biglietto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Chistolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Holt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lies","family":"Lahousse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Pola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Becattini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Vedovati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.thromres.2026.109752_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12185955","article-title":"Management of patients treated with direct oral anticoagulants in clinical practice and challenging scenarios","volume":"12","author":"Luc\u00e0","year":"2023","journal-title":"J. Clin. Med."},{"issue":"11","key":"10.1016\/j.thromres.2026.109752_bb0010","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/archsurg.135.11.1265","article-title":"Effects of steroids and retinoids on wound healing","volume":"135","author":"Wicke","year":"2000","journal-title":"Arch. Surg."},{"issue":"1","key":"10.1016\/j.thromres.2026.109752_bb0015","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/0194599819832277","article-title":"Epistaxis risk associated with intranasal corticosteroid sprays: a systematic review and meta-analysis","volume":"161","author":"Wu","year":"2019","journal-title":"Otolaryngol. Head Neck Surg."},{"issue":"3","key":"10.1016\/j.thromres.2026.109752_bb0020","doi-asserted-by":"crossref","first-page":"206.e1","DOI":"10.1016\/j.ajog.2013.06.045","article-title":"Abnormal vaginal bleeding after epidural steroid injection: a paired observation cohort study","volume":"209","author":"Suh-Burgmann","year":"2013","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.thromres.2026.109752_bb0025","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4103\/0019-5154.139872","article-title":"Topical steroid-damaged skin","volume":"59","author":"Abraham","year":"2014","journal-title":"Indian J. Dermatol."},{"key":"10.1016\/j.thromres.2026.109752_bb0030","article-title":"Major bleeding risk assessment in patients with cancer-associated venous thromboembolism treated with DOACs: data from a multicenter cohort","author":"Vedovati","year":"2025","journal-title":"Thromb. Haemost."},{"issue":"9","key":"10.1016\/j.thromres.2026.109752_bb0035","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.recesp.2021.06.016","article-title":"Declaraci\u00f3n PRISMA 2020: una gu\u00eda actualizada para la publicaci\u00f3n de revisiones sistem\u00e1ticas","volume":"74","author":"Page","year":"2021","journal-title":"Rev. Esp. Cardiol. (Engl. Ed.)"},{"issue":"1","key":"10.1016\/j.thromres.2026.109752_bb0040","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1538-7836.2009.03678.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients","volume":"8","author":"Schulman","year":"2010","journal-title":"J. Thromb. Haemost."},{"issue":"9","key":"10.1016\/j.thromres.2026.109752_bb0045","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.thromres.2026.109752_bb0050","doi-asserted-by":"crossref","DOI":"10.1111\/jre.13405","article-title":"Risk of bias evaluation of cross-sectional studies: adaptation of the Newcastle-Ottawa scale","author":"Carra","year":"2025","journal-title":"J. Periodontal Res."},{"key":"10.1016\/j.thromres.2026.109752_bb0055","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.thromres.2026.109752_bb0060","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ejca.2021.02.026","article-title":"Effects of concomitant administration of anticancer agents and apixaban or dalteparin on recurrence and bleeding in patients with cancer-associated venous thromboembolism","volume":"148","author":"Verso","year":"2021","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"10.1016\/j.thromres.2026.109752_bb0065","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s11239-023-02879-7","article-title":"Screening for clinically relevant drug-drug interactions between direct oral anticoagulants and antineoplastic agents: a pharmacovigilance approach","volume":"56","author":"Truong","year":"2023","journal-title":"J. Thromb. Thrombolysis"},{"issue":"1","key":"10.1016\/j.thromres.2026.109752_bb0070","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-77174-z","article-title":"Clinical factors associated with safety and efficacy in patients receiving direct oral anticoagulants for non-valvular atrial fibrillation","volume":"10","author":"Yamato","year":"2020","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.thromres.2026.109752_bb0075","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1136\/heartjnl-2021-319503","article-title":"Gastrointestinal bleeding risk following concomitant treatment with oral glucocorticoids in patients on non-vitamin K oral anticoagulants","volume":"108","author":"Holt","year":"2022","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.thromres.2026.109752_bb0080","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10557-023-07521-5","article-title":"Pharmacodynamic drug-drug interactions and bleeding outcomes in patients with atrial fibrillation using non-vitamin K antagonist oral anticoagulants: a nationwide cohort study","volume":"39","author":"Grymonprez","year":"2025","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"6","key":"10.1016\/j.thromres.2026.109752_bb0085","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1002\/cpt.2369","article-title":"Association between use of pharmacokinetic-interacting drugs and effectiveness and safety of direct acting oral anticoagulants: nested case-control study","volume":"110","author":"Gronich","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"issue":"8","key":"10.1016\/j.thromres.2026.109752_bb0090","doi-asserted-by":"crossref","DOI":"10.1111\/cts.70311","article-title":"Comparative risk of major bleeding with concomitant use of oral anticoagulants and corticosteroid bursts","volume":"18","author":"Yao","year":"2025","journal-title":"Clin. Transl. Sci."},{"issue":"1","key":"10.1016\/j.thromres.2026.109752_bb0095","doi-asserted-by":"crossref","DOI":"10.4084\/MJHID.2025.022","article-title":"Direct oral anticoagulants (DOACs) in the onco-hematologic patients","volume":"17","author":"Biglietto","year":"2025","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"issue":"9921","key":"10.1016\/j.thromres.2026.109752_bb0100","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.thromres.2026.109752_bb0105","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/jth.12605","article-title":"Meta-analysis of the efficacy and safety of new oral anticoagulants in patients with cancer-associated acute venous thromboembolism","volume":"12","author":"van der Hulle","year":"2014","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2026.109752_bb0110","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.k2505","article-title":"Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care","author":"Vinogradova","year":"2018","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.thromres.2026.109752_bb0115","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/joim.13712","article-title":"Association of type of oral anticoagulation with risk of bleeding in 45,114 patients with venous thromboembolism during initial and extended treatment\u2014a nationwide register-based study","volume":"294","author":"Glise Sandblad","year":"2023","journal-title":"J. Intern. Med."},{"issue":"11","key":"10.1016\/j.thromres.2026.109752_bb0120","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1093\/europace\/euac020","volume":"24","author":"Gorog","year":"2022","journal-title":"Europace"},{"issue":"Supplement 1","key":"10.1016\/j.thromres.2026.109752_bb0125","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1182\/blood-2018-99-111207","article-title":"Evaluation of definitions for oral anticoagulant\u2013associated major bleeding: a population-based cohort study","volume":"132","author":"Xu","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2026.109752_bb0130","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.thromres.2022.02.018","article-title":"Evaluation of definitions for oral anticoagulant-associated major bleeding: a population-based cohort study","volume":"213","author":"Xu","year":"2022","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.thromres.2026.109752_bb0135","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1182\/hematology.2024000666","article-title":"DOACs: role of anti-Xa and drug level monitoring","volume":"2024","author":"Mithoowani","year":"2024","journal-title":"Hematology"},{"issue":"2","key":"10.1016\/j.thromres.2026.109752_bb0140","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/ijlh.14483","article-title":"Measuring direct oral anticoagulant (DOAC) levels: applications, limitations, and future directions","volume":"48","author":"Mithoowani","year":"2026","journal-title":"Int. J. Lab. Hematol."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384826001714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384826001714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:44:34Z","timestamp":1784133874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384826001714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":28,"alternative-id":["S0049384826001714"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109752","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bleeding risk in patients receiving concurrent treatment with direct oral anticoagulants and corticosteroids: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109752","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109752"}}